Terry Fox Molecular Oncology Group and the Bloomfield Center for Research on Aging; Sir Mortimer B Davis Jewish General Hospital; Lady Davis Institute for Medical Research; Montréal, QC Canada; Department of Medicine and Oncology; McGill University; Montréal, QC Canada.
Epigenetics. 2013 Nov;8(11):1162-75. doi: 10.4161/epi.26112. Epub 2013 Aug 22.
The histone lysine demethylase KDM5B plays key roles in gene repression by demethylating trimethylated lysine 4 of histone H3 (H3K4me3), a modification commonly found at the promoter region of actively transcribed genes. KDM5B is known to regulate the expression of genes involved in cell cycle progression; however, little is known about the post-translational modifications that regulate KDM5B. Herein, we report that KDM5B is SUMOylated at lysine residues 242 and 278 and that the ectopic expression of the hPC2 SUMO E3 ligase enhances this SUMOylation. Interestingly, the levels of KDM5B and its SUMOylated forms are regulated during the cell cycle. KDM5B is modulated by RNF4, an E3 ubiquitin ligase that targets SUMO-modified proteins to proteasomal degradation. Digital gene expression analyses showed that cells expressing the SUMOylation-deficient KDM5B harbor repressed mRNA expression profiles of cell cycle and DNA repair genes. Chromatin immunoprecipitations confirmed some of these genes as KDM5B targets, as they displayed reduced H3K4me3 levels in cells ectopically expressing KDM5B. We propose that SUMOylation by hPC2 regulates the activity of KDM5B.
组蛋白赖氨酸去甲基化酶 KDM5B 通过去甲基化组蛋白 H3 上的三甲基赖氨酸 4(H3K4me3)发挥基因抑制的关键作用,该修饰通常存在于活跃转录基因的启动子区域。已知 KDM5B 调节细胞周期进程中涉及的基因的表达;然而,对于调节 KDM5B 的翻译后修饰知之甚少。在此,我们报告 KDM5B 在赖氨酸残基 242 和 278 处被 SUMO 化,并且 hPC2 SUMO E3 连接酶的异位表达增强了这种 SUMO 化。有趣的是,KDM5B 的水平及其 SUMO 化形式在细胞周期中受到调节。KDM5B 受 RNF4 调节,RNF4 是一种 E3 泛素连接酶,可将 SUMO 修饰的蛋白质靶向蛋白酶体降解。数字基因表达分析表明,表达 SUMO 化缺陷型 KDM5B 的细胞具有受抑制的细胞周期和 DNA 修复基因的 mRNA 表达谱。染色质免疫沉淀证实了这些基因中的一些是 KDM5B 的靶标,因为它们在异位表达 KDM5B 的细胞中显示出 H3K4me3 水平降低。我们提出 hPC2 的 SUMO 化调节 KDM5B 的活性。